Pfeffer, PaulAli, NasloonMurray, RuthUlrik, CharlotteTran, TrungMaspero, JorgePeters, MatthewChristoff, GeorgeSadatsafavi, MohsenTorres-Duque, Carlos A.Altraja, AlanLehtimäki, LauriPapadopoulos, NikolaosSalvi, SundeepCostello, Richard W.Cushen, BredaHeffler, EnricoIwanaga, TakashiAl-Ahmad, MonaLarenas-Linnemann, DésiréeKuna, PiotrFonseca, JoãoAl-Lehebi, RiyadRhee, Chin KookLlano, Luis Perez dePerng, Diahn-WangMahboub, BassamWang, EileenGoh, Yun Yi CelineLyu, JuntaoNewell, AnthonyAlacqua, MariannaBhutani, MohitBjermer, LeifBjörnsdóttir, Unnur SteinaBourdin, ArnaudBülow, Anna VonBusby, JohnCanonica, WalterCosio, Borja GDorscheid, DelbertEsquerre, Mariana MuñozFitzGerald, MarkGil, Esther GarciaGibson, Peter GerardHeaney, LiamHew, MarkHilberg, OleHoyte, FlaviaJackson, DavidKoh, MarikoKo, Hsin-KuoLee, Jae HaLehmann, SverreLoureiro, Claudia ChavesLudviksdottir, DoraMenzies-Gow, AndrewMitchell, PatrickPapaioannou, AndrianaPopov, TodorPorsbjerg, CelesteSalameh, LailaSirena, ConcettaTaillé, CamilleTaube, ChristianTohda, YujiWechsler, M. E.Price, David2023-03-282023-03-282023-07Pfeffer, P, Ali, N, Murray, R, Ulrik, C, Tran, T, Maspero, J, Peters, M, Christoff, G, Sadatsafavi, M, Torres-Duque, C A, Altraja, A, Lehtimäki, L, Papadopoulos, N, Salvi, S, Costello, R W, Cushen, B, Heffler, E, Iwanaga, T, Al-Ahmad, M, Larenas-Linnemann, D, Kuna, P, Fonseca, J, Al-Lehebi, R, Rhee, C K, Llano, L P D, Perng, D-W, Mahboub, B, Wang, E, Goh, Y Y C, Lyu, J, Newell, A, Alacqua, M, Bhutani, M, Bjermer, L, Björnsdóttir, U S, Bourdin, A, Bülow, A V, Busby, J, Canonica, W, Cosio, B G, Dorscheid, D, Esquerre, M M, FitzGerald, M, Gil, E G, Gibson, P G, Heaney, L, Hew, M, Hilberg, O, Hoyte, F, Jackson, D, Koh, M, Ko, H-K, Lee, J H, Lehmann, S, Loureiro, C C, Ludviksdottir, D, Menzies-Gow, A, Mitchell, P, Papaioannou, A, Popov, T, Porsbjerg, C, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, M E & Price, D 2023, 'Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both', Allergy, vol. 78, no. 7, pp. 1934-1948. https://doi.org/10.22541/au.166563547.79282253/v1, https://doi.org/10.1111/all.157110105-4538unpaywall: 10.22541/au.166563547.79282253/v1https://hdl.handle.net/2164/20355Open access via the Wiley Agreement Acknowledgements In memory of Professor J. Mark Fitzgerald, the authors would like to acknowledge him for his valuable contribution to the development of the manuscript. The authors also acknowledge Ms. Daniela Morrone (MSc) of Cromsource, Verona, Italy for her contribution during the development of the manuscript and Mr. Joash Tan (BSc, Hons) of the Observational and Pragmatic Research Institute (OPRI), for editorial and formatting assistance that supported the development of this publication.152479744engbiologicsexacerbationISARreal lifeoral corticosteroidsR MedicineRComparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for bothJournal article10.22541/au.166563547.79282253/v1787